Thermo Fisher Scientific Revenues Rise 54 Percent in Q4, 26 Percent for Full Year 2020

Feb 01, 2021

|

This article has been updated with information from Thermo Fisher's quarterly earnings call.

NEW YORK – Thermo Fisher Scientific on Monday reported a 54 percent increase in fourth quarter revenues and a 26 percent rise in full-year 2020 revenues, driven by products and services related to the COVID-19 pandemic response.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Thermo Fisher Scientific Revenues Rise 54 Percent in Q4, 26 Percent for Full Year 2020

To read the full story....

Breaking News

Biden Administration Funds $1B for COVID-19 Testing in Indian Country

Scope Fluidics Gets CE Mark for Rapid MRSA MDx Panel

NIH Awards Qorvo Biotechnologies $24.4M for Rapid SARS-CoV-2 Antigen Test

In Brief This Week: Exact Sciences, Siemens Healthineers, Seegene, Agilent Technologies, and More

Color Health, Yale Get FDA Emergency Use Authorization for Coronavirus Sample Collection Kits

Veracyte Preliminary Q1 Revenues Up 16 to 19 Percent, CFO to Retire

What's Popular?

With Luminex Acquisition, DiaSorin to Broaden MDx Portfolio, Expand US Presence

Color Health, Yale Get FDA Emergency Use Authorization for Coronavirus Sample Collection Kits

Siemens Healthineers Gets CE Mark for Point-of-Care High-Sensitivity Cardiac Troponin I Test

Thermo Fisher Scientific Gets FDA EUA for High-Throughput, Automated COVID-19 Test Kit

Antelope Dx Collaborates With In The Pocket, Extra Horizon to Develop Self-Tests

Sponsorships